Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02417415 · ClinicalTrials.gov registry record · NA

Local Heat Stress in Autonomic Failure Patients With Supine Hypertension

A NA study, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT02417415: Completed NA study, sponsored by Vanderbilt University.

NCT02417415 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02417415, a NA study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

Patients with autonomic failure are characterized by disabling orthostatic hypotension (low blood pressure on standing), and at least half of them also have high blood pressure while lying down (supine hypertension). Exposure to heat, such as in hot environments, often worsens their orthostatic hypotension. The causes of this are not fully understood. The purpose of this study is to evaluate whether applying local heat over the abdomen of patients with autonomic failure and supine hypertension would decrease their high blood pressure while lying down. This will help us better understand the mechanisms underlying this phenomenon, and may be of use in the treatment of supine hypertension.

Primary Outcome

Change from baseline in systolic blood pressure at 2 hr post-intervention

Interventions

  • OTHER Passive heat stress
  • OTHER Control (non-heating)

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2015-04
Est. Completion 2021-02
Phase NA
Vanderbilt University

430 total trials

What the finished NCT02417415 record still lists

NCT02417415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Passive heat stress is the first listed.

NCT02417415 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02417415 about?

NCT02417415 is a clinical study titled "Local Heat Stress in Autonomic Failure Patients With Supine Hypertension". Patients with autonomic failure are characterized by disabling orthostatic hypotension (low blood pressure on standing), and at least half of them also have high blood pressure while lying down (supine hypertension). Exposure to heat, such as in hot environments, often worsens their orthostatic hypo...

What is the current status of trial NCT02417415?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2015-04. Estimated completion is 2021-02.

What interventions are being tested in trial NCT02417415?

The interventions under investigation include: Passive heat stress (OTHER), Control (non-heating) (OTHER).

Who is sponsoring clinical trial NCT02417415?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02417415's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02417415, the US trial registry maintained by the National Library of Medicine. NCT02417415 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.